Ebvaciclib | MedChemExpress (MCE)
PF-06873600 is a selective and orally bioavailable inhibitor of cyclin-dependent kinase (CDK), with Ki values of 0.09 nM, 0.13 nM and 0.16 nM for CDK2, CDK4 and CDK6, respectively. PF-06873600 has potential antineoplastic activity[1][2].
| Trivial name | Ebvaciclib |
| Catalog Number | HY-114177 |
| Alternative Name(s) | PF-06873600 |
| Research Area | Cancer |
| CAS# | 2185857-97-8 |
| Purity | 100.0% |
| SMILES | O=C1N([C@H]2[C@](O)(CCC2)C)C3=NC(NC4CCN(CC4)S(C)(=O)=O)=NC=C3C=C1C(F)F |
| Size | 100 mg |
| Supplier Page | https://www.medchemexpress.com/PF-06873600.html |